NCT02180880View on ClinicalTrials.gov

Symptom Based Treatment of Neuropathic Pain

PHASE4CompletedINTERVENTIONAL
Enrollment

63

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

August 31, 2014

Study Completion Date

August 31, 2014

Conditions
NeuralgiaSpinal Cord Injury
Interventions
DRUG

Pregabalin and Oxcarbazepine

"Subjects will take pregabalin for the duration of 2 weeks. The dosage will be increased from 75 mg twice to 150 mg twice a day.~Subjects will stop pregabalin for 1 week and take oxcarbazepine 150mg twice."

Trial Locations (1)

463-712

CHA University, Seongnam-si

All Listed Sponsors
lead

Ju Seok Ryu

OTHER

NCT02180880 - Symptom Based Treatment of Neuropathic Pain | Biotech Hunter | Biotech Hunter